I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 22 studies | 36% ± 13% | |
| regulatory T cell | 20 studies | 35% ± 14% | |
| CD8-positive, alpha-beta T cell | 17 studies | 28% ± 10% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 12 studies | 40% ± 14% | |
| mucosal invariant T cell | 10 studies | 36% ± 12% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 10 studies | 43% ± 14% | |
| T cell | 10 studies | 31% ± 10% | |
| gamma-delta T cell | 8 studies | 25% ± 7% | |
| CD8-positive, alpha-beta memory T cell | 7 studies | 25% ± 7% | |
| CD4-positive, alpha-beta memory T cell | 7 studies | 41% ± 17% | |
| effector memory CD8-positive, alpha-beta T cell | 6 studies | 23% ± 9% | |
| T-helper 17 cell | 5 studies | 30% ± 17% | |
| effector CD4-positive, alpha-beta T cell | 4 studies | 33% ± 13% | |
| effector memory CD4-positive, alpha-beta T cell | 4 studies | 44% ± 15% | |
| central memory CD8-positive, alpha-beta T cell | 3 studies | 19% ± 5% | |
| natural killer cell | 3 studies | 20% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 19% ± 1% | |
| mature NK T cell | 3 studies | 19% ± 5% |
